MEHLMAN CONSULTING, INC.

Lobbying for VIZIENT INC · Healthcare services company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

340b drug pricing program. Health care workforce. Health care supply chain. Health care drug shortages.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.